Insider Stock Trading History of Sharp Philip A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sharp Philip A since year 2005. The trader's CIK number is 1226295. At the time of this reporting, Sharp Philip A is the Director of Alnylam Pharmaceuticals, Inc. . (stock ticker symbol ALNY). See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .

Note that in the past SHARP PHILIP A also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Sharp Philip A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-01 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 25,000 31.29 782,250
2017-02-01 ALNY Alnylam Pharmaceuticals, Inc. Sale 25,000 39.94 998,500
2017-01-25 ALNY Alnylam Pharmaceuticals, Inc. Sale 15,000 37.95 569,250
2017-01-25 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 15,000 31.39 470,850
2017-01-18 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 15,000 15.91 238,650
2017-01-18 ALNY Alnylam Pharmaceuticals, Inc. Sale 15,000 37.88 568,275
2015-12-04 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 30,000 14.39 431,850
2015-12-04 ALNY Alnylam Pharmaceuticals, Inc. Sale 30,000 109.00 3,270,000
2014-10-13 ALNY Alnylam Pharmaceuticals, Inc. Sale 110,000 85.00 9,350,000
2014-10-13 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 110,000 7.42 816,750
2013-01-22 ALNY Alnylam Pharmaceuticals, Inc. Buy 4,967 20.13 99,985
2012-02-21 ALNY Alnylam Pharmaceuticals, Inc. Buy 9,302 10.75 99,996
2008-07-21 BIIB Biogen Idec Inc Sale 72,500 68.00 4,930,000
2008-07-21 BIIB Biogen Idec Inc Option Ex 72,500 35.42 2,567,950
2008-04-08 BIIB Biogen Idec Inc Option Ex 100,000 35.42 3,542,000
2008-04-08 BIIB Biogen Idec Inc Sale 76,850 64.20 4,933,616
2008-04-08 BIIB Biogen Idec Inc Sale 15,650 64.63 1,011,428
2008-04-08 BIIB Biogen Idec Inc Sale 7,500 64.87 486,525
2007-05-25 BIIB Biogen Idec Inc Option Ex 1,250 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sharp Philip A (Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.